Aurora Cannabis boosts stakes in Cann Group and Radient Technologies

By zaymalz malz

Canada’s Aurora Cannabis has accelerated its investment strategy, having increased its stake in Cann Group, whilst also being in the process of acquiring more shares from Radient Technologies.

Aurora has revealed that it will be spending up to AUS$60mn (CAD$57.9mn) to boost its ownership in the Australian-based Cann Group from 19.9% to 22.9%. Whilst an initial investment of AUS$50mn (CAD$48.2mn) has been processed, the remaining two phases of investment won’t complete until 15 January 2018.

See also:

“Cann is the leading cannabis company in Australia, having been awarded the first ever license, and funding the acceleration of its expansion plans makes strong strategic sense,” said Terry Booth, Aurora's CEO.

“The value of our initial $6.5 million investment, based on Cann's closing share price as of Friday 1 December 2017, has already increased ten-fold to $65 million, and we have strong confidence in the Cann team to continue executing on their expansion plan and generate further shareholder value in the process.”

Further, Aurora also announced that it would be investing a further CAD$6.2mn into Radient technologies – a company that extracts natural compounds from a range of materials using microwave assisted processing.

“With multiple Aurora facilities coming online and ramping up production in the coming quarters, as well as the anticipated export of cannabis oils and preparations for the legalization of adult consumer use in Canada, Radient's planned expansion positions both companies exceptionally well to accelerate revenue growth,” Booth said.

“This investment reflects our strategy to build a constellation of vertically integrated partners and subsidiaries, and we look forward to jointly pursuing further expansion of market share in this exiting space.”

Aurora has been attempting to considerably expand its operations of late, with the expectation that Canada will legalise the production, sale and consumption Marijuana.

This has included the company attempting to buy CanniMed Therapeutics.

Share

Featured Articles

Top 10 must-read sustainable leadership books for CEOs

As former Unilever boss Paul Polman debuts his new net zero book, we ask – can profit and purpose truly exist? Here are 10 business books to prove they can

Top 20 essential leadership resources for Black executives

To celebrate Black History Month, here are 20 resources for Black leaders – from business books to leadership coaches to business school exec programs

Broadridge study reveals huge impact of AI on C-suite

Broadridge Financial Solutions spoke to 500 C-suite executives from across the globe, many of whom said AI was significantly changing the way they work

PwC's Kathryn Kaminsky – the role of boards on social issues

Leadership & Strategy

Why your business needs a Chief Transformation Officer

Leadership & Strategy

12 top AI and ML trends for the enterprise in 2023 – Dataiku

Technology & AI